Clinical profile, management and outcomes of class IV emphysematous pyelonephritis in a tertiary care center: A retrospective descriptive study

Keywords: emphysematous pyelonephritis, kidney, Escherichia coli, double J stent, acute kidney injury

Abstract

Abstract. Class IV Emphysematous pyelonephritis (EPN) is a life-threatening infection of the kidney, and there is sparse data on immediate and long-term outcomes of medical management. The study aimed to review the clinical presentation, diagnosis, immediate and long-term outcomes of medical management, and outcome of patients presenting with class IV EPN

Methods. This retrospective study was conducted in a tertiary care center in Dharwad, India. The study included class IV EPN patients admitted to the hospital between Jan 2012 to Dec 2019. The factors studied were demographics, comorbidities, radiological investigations, clinical presentation, urine, blood and pus culture, and sensitivity and treatment history. Immediate and long-term outcomes of medical management were determined. Descriptive analysis of the data was conducted. Continuous variables were presented as mean ± standard deviation and discrete variables in terms of number (%).

Results. Twenty-one patients with class IV EPN, with a mean age of 55.7 ±13.5 years, were analyzed. The majority were males (M: F 15:6). The patients were followed up for 32.70±21.12 months. Fever, flank or abdominal pain, and acute kidney injury were observed in all 21 patients, while nausea and/or vomiting and dysuria were seen in 16 (76.2%) patients. E. Coli was the most common pathogen found. Double J stenting was done in 20 (95.2%) patients; Ultrasonography guided aspiration 8(38.1%) and percutaneous drainage in 5 (23.8%) patients. One (4.8%) patient died during the first episode and 3(19%) others due to recurrent infection and end-stage renal disease.

Conclusions. Class IV Emphysematous pyelonephritis can be managed successfully by minimally invasive modalities. However, long-term morbidity and mortality risks are still negative.

Downloads

Download data is not yet available.

References

Kelly HA, Maccallum WG. Pneumaturia. JAMA. 1898;XXXI(8):375–81. doi:10.1001/jama.1898.92450080001001.

Eswarappa M, Suryadevara S, John MM, Kumar M, Reddy SB, Suhail M. Emphysematous Pyelonephritis case series from south India. Kidney Int Rep. 2018;3(4):950-55. doi: 10.1016/j.ekir.2017.12.003.

Butler J, Bhatt RT, Amante G. Emphysematous pyelonephritis - Is surgery necessary? New Horizons in Clinical Case Reports. 2017;2:30. http://dx.doi.org/10.1016/j.nhccr.2017.10.024.

Falagas ME, Alexiou VG, Giannopoulou KP, Siempos II. Risk factors for mortality in patients with emphysematous pyelonephritis: a meta-analysis. J Urol. 2007 Sep;178(3 Pt 1):880-5; quiz 1129. doi: 10.1016/j.juro.2007.05.017.

Karthikeyan VS, Manohar CM, Mallya A, Keshavamurthy R, Kamath AJ. Clinical profile and successful outcomes of conservative and minimally invasive treatment of emphysematous pyelonephritis. Cent European J Urol. 2018;71(2):228-33. doi: 10.5173/ceju.2018.1639.

Huang JJ, Tseng CC. Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis. Arch Intern Med. 2000 Mar 27;160(6):797-805. doi: 10.1001/archinte.160.6.797.

Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005 Jun;67(6):2089-100. doi: 10.1111/j.1523-1755.2005.00365.x.

Deoraj S, Zakharious F, Nasim A, Missouris C. Emphysematous pyelonephritis: outcomes of conservative management and literature review. BMJ Case Rep. 2018 Sep 12;2018:bcr2018225931. doi: 10.1136/bcr-2018-225931.

Lin WR, Chen M, Hsu JM, Wang CH. Emphysematous pyelonephritis: patient characteristics and management approach. Urol Int. 2014;93(1):29-33. doi: 10.1159/000353798.

Irfaan AM, Shaikh NA, Jamshaid A, Qureshi AH. Emphysematous Pyelonephritis: A single center review. Pak J Med Sci. 2020 Jan;36(1):S83-S86. doi: 10.12669/pjms.36.ICON-Suppl.1728.

Alaparthi P, Rao SN, Shenoy MP. Emphysematous pyelonephritis – A case series from a single centre in Southern India. J Clini Nephrol. 2018; 2: 020-024. doi: 10.29328/journal.jcn.1001014.

Lu YC, Chiang BJ, Pong YH, Chen CH, Pu YS, Hsueh PR, et al. Emphysematous pyelonephritis: clinical characteristics and prognostic factors. Int J Urol. 2014 Mar;21(3):277-82. doi: 10.1111/iju.12244.

Abdul-Halim H, Kehinde EO, Abdeen S, Lashin I, Al-Hunayan AA, Al-Awadi KA. Severe emphysematous pyelonephritis in diabetic patients: diagnosis and aspects of surgical management. Urol Int. 2005;75(2):123-8. doi: 10.1159/000087165.

Tang HJ, Li CM, Yen MY, Chen YS, Wann SR, Lin HH, et al. Clinical characteristics of emphysematous pyelonephritis. J Microbiol Immunol Infect. 2001 Jun;34(2):125-30. Available from: https://pubmed.ncbi.nlm.nih.gov/11456358/.

Somani BK, Nabi G, Thorpe P, Hussey J, Cook J, N'Dow J. ABACUS Research Group. Is percutaneous drainage the new gold standard in the management of emphysematous pyelonephritis? Evidence from a systematic review. J Urol. 2008 May;179(5):1844-9. doi: 10.1016/j.juro.2008.01.019.

Khaira A, Gupta A, Rana DS, Gupta A, Bhalla A, Khullar D. Retrospective analysis of clinical profile prognostic factors and outcomes of 19 patients of emphysematous pyelonephritis. Int Urol Nephrol. 2009 Dec;41(4):959-66. doi: 10.1007/s11255-009-9552-y.

Olvera-Posada D, Armengod-Fischer G, Vázquez-Lavista LG, Maldonado-Ávila M, Rosas-Nava E, Manzanilla-García H, et al. Emphysematous pyelonephritis: multicenter clinical and therapeutic experience in Mexico. Urology. 2014 Jun;83(6):1280-4. doi: 10.1016/j.urology.2014.02.010.

Kuzgunbay B, Turunc T, Tokmak N, Turunc T, Dirim A, Aygun C, et al. Tailored treatment approach for emphysematous pyelonephritis. Urol Int. 2011;86(4):444-7. doi: 10.1159/000323604.

Aboumarzouk OM, Hughes O, Narahari K, Coulthard R, Kynaston H, Chlosta P, et al. Emphysematous pyelonephritis: Time for a management plan with an evidence-based approach. Arab J Urol. 2014 Jun;12(2):106-15. doi: 10.1016/j.aju.2013.09.005.

Pontin AR, Barnes RD. Current management of emphysematous pyelonephritis. Nat Rev Urol. 2009 May;6(5):272-9. doi: 10.1038/nrurol.2009.51.

Huang JJ, Chen KW, Ruaan MK. Mixed acid fermentation of glucose as a mechanism of emphysematous urinary tract infection. J Urol. 1991 Jul;146(1):148-51. doi: 10.1016/s0022-5347(17)37736-4.

Shokeir AA, El-Azab M, Mohsen T, El-Diasty T. Emphysematous pyelonephritis: a 15-year experience with 20 cases. Urology. 1997 Mar;49(3):343-6. doi: 10.1016/S0090-4295(96)00501-8.

Makris K, Spanou L. Acute Kidney Injury: Definition, Pathophysiology and Clinical Phenotypes. Clin Biochem Rev. 2016 May;37(2):85-98. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198510/.

Fatima R, Jha R, Muthukrishnan J, Gude D, Nath V, Shekhar S, et al. Emphysematous pyelonephritis: A single center study. Indian J Nephrol. 2013 Mar;23(2):119-24. doi: 10.4103/0971-4065.109418.

Michaeli J, Mogle P, Perlberg S, Heiman S, Caine M. Emphysematous pyelonephritis. J Urol. 1984 Feb;131(2):203-8. doi: 10.1016/s0022-5347(17)50309-2.

Das D, Pal DK. Double J stenting: A rewarding option in the management of emphysematous pyelonephritis. Urol Ann. 2016 Jul-Sep;8(3):261-4. doi: 10.4103/0974-7796.184881.

Kapoor R, Muruganandham K, Gulia AK, Singla M, Agrawal S, Mandhani A, Ansari MS, Srivastava A. Predictive factors for mortality and need for nephrectomy in patients with emphysematous pyelonephritis. BJU Int. 2010 Apr;105(7):986-9. doi: 10.1111/j.1464-410X.2009.08930.x.

Jain A, Manikandan R, Dorairajan LN, Sreenivasan SK, Bokka S. Emphysematous pyelonephritis: Does a standard management algorithm and a prognostic scoring model optimize patient outcomes? Urol Ann. 2019 Oct-Dec;11(4):414-420. doi: 10.4103/UA.UA_17_19.

Misgar RA, Mubarik I, Wani AI, Bashir MI, Ramzan M, Laway BA. Emphysematous pyelonephritis: A 10-year experience with 26 cases. Indian J Endocrinol Metab. 2016 Jul-Aug;20(4):475-80. doi: 10.4103/2230-8210.183475.

 


Abstract views: 502
PDF Downloads: 17796
Published
2021-10-12
How to Cite
Manjunath, R., Bennikal, M., Dasar, S., & Patil, S. (2021). Clinical profile, management and outcomes of class IV emphysematous pyelonephritis in a tertiary care center: A retrospective descriptive study. Ukrainian Journal of Nephrology and Dialysis, (4(72), 78-85. https://doi.org/10.31450/ukrjnd.4(72).2021.10